ZBTB20 and cancer: Therefore, we selected proteins that were significantly lower expressed in cancer both in the CPTAC Discovery study and the Chinese-LUAD study, and found that two of the predicted substrates, namely ZBTB20 and GLUD1 (Figure 4A), were lower in cancer (Figure 4B–E).